denileukin diftitox

Modify Date: 2025-08-27 13:37:12

denileukin diftitox Structure
denileukin diftitox structure
Common Name denileukin diftitox
CAS Number 173146-27-5 Molecular Weight N/A
Density N/A Boiling Point N/A
Molecular Formula N/A Melting Point N/A
MSDS N/A Flash Point N/A

 Use of denileukin diftitox


Denileukin diftitox (DAB 389IL-2) is a diphtheria toxin (DT)-related interleukin 2 (IL-2) fusion protein toxin that depletes cells expressing the high-affinity form of the IL-2 receptor (IL-2R), CD25. Denileukin diftitox binds to cells expressing IL-2R and inhibits protein synthesis through internalization of the diphtheria toxin fragment[1][2][3].

 Names

Name denileukin diftitox
Synonym More Synonyms

 denileukin diftitox Biological Activity

Description Denileukin diftitox (DAB 389IL-2) is a diphtheria toxin (DT)-related interleukin 2 (IL-2) fusion protein toxin that depletes cells expressing the high-affinity form of the IL-2 receptor (IL-2R), CD25. Denileukin diftitox binds to cells expressing IL-2R and inhibits protein synthesis through internalization of the diphtheria toxin fragment[1][2][3].
Related Catalog
Target

IL-2 receptor (IL-2R), CD25[1]

In Vitro Denileukin diftitox (DAB 389IL-2) 是一种 3 结构域融合蛋白毒素,由白喉毒素 (DT) 催化结构域、白喉毒素 (DT) 膜易位结构域和取代天然白喉毒素 (DT) 受体结合结构域的人 IL-2 组成[1]。 Denileukin diftitox (1-1000 pM; HUT 102/6TG 细胞) 对于体外携带高亲和力 IL-2 受体的细胞系细胞毒效力增加了大约 17 倍[3]。
In Vivo Denileukin diftitox (DAB 389IL-2; 35 μg/kg; i.p.; 感染 H37Rv 的 C57BL/6 小鼠) 在小鼠模型中抑制分枝杆菌复制并降低 Treg 和髓源性抑制细胞 (MDSC) 的频率[1]。 Denileukin diftitox (2.5 或 3 μg/头; i.v.) 在小鼠模型中具有抗肿瘤活性并抑制肿瘤生长[2]。 Animal Model: C57BL/6 mice with infected H37Rv[1] Dosage: 35 μg/kg Administration: Intraperitoneal injection; twice a week, for 2 weeks Result: Reduced the colony-forming unit (CFU) numbers in lungs and spleens. Reduces Treg and MDSC frequencies in lungs and spleens. Animal Model: Female BALB/c mice with tumor models[2] Dosage: 2.5 or 3 μg/head Administration: Intravenous injection; weekly, for 2 or 3 weeks Result: Inhibited the growth of tumors.
References

[1]. Gupta S, et, al. Suppressor Cell-Depleting Immunotherapy With Denileukin Diftitox is an Effective Host-Directed Therapy for Tuberculosis. J Infect Dis. 2017 Jun 15;215(12):1883-1887.  

[2]. Albu DI, et, al. Preclinical immune antitumor activity of myeloid-targeting E7046 and Treg depleting E7777. Cancer Immunol Res (2016) 4 (1_Supplement): B034.

[3]. Kiyokawa T, et, al. Protein engineering of diphtheria-toxin-related interleukin-2 fusion toxins to increase cytotoxic potency for high-affinity IL-2-receptor-bearing target cells. Protein Eng. 1991 Apr;4(4):463-8.  

 Chemical & Physical Properties

No Any Chemical & Physical Properties

 Synonyms

DENILEUKIN DIFTITOX
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.
Top Suppliers:I want be here




Get all suppliers and price by the below link:

denileukin diftitox suppliers

denileukin diftitox price